Dermavant Sciences, Inc

Huntington Medical Research Institutes is nonprofit, public-benefit organization dedicated to improving health and prolonging life by enhancing knowledge of life processes and disease and developing technology to diagnose and treat diseases. Its developments include the hydrocephalus shunt to treat water-on-the-brain, studies on biomedical applications of laser energy, cancer research, electronic neural rehabilitation technology and applications of medical magnetic resonance imaging and spectroscopy. Huntington Medical Research Institutes was founded in 1952 and operates in five locations in Pasadena, Calif.

Anivive is a pioneering pet pharmaceutical company located in Long Beach, California, dedicated to developing innovative treatments for pets suffering from various health conditions, including Valley Fever. Their advancements in biologics and molecular pathology aim to provide lasting hope for families in need of effective veterinary care. With a commitment to discovery and clinical benefit, Anivive actively engages in trials and research to enhance the lives of pets and their owners. The company embodies a spirit of social responsibility, emphasizing the importance of pet health and well-being through its extensive resources and success stories. Generated from the website

Dendreon is a leading company in Seal Beach, CA, revolutionizing medicine through their expertise in cellular technology. With a focus on improving the lives of patients, they develop innovative science and cellular therapies, enabling the future of complex cell therapies through research, development, and strategic partnerships. As pioneers in the field, Dendreon's flagship innovation, PROVENGE sipuleucel-T, was the first FDA-approved cellular immunotherapy available in the market. With their extensive experience, knowledge, and logistics, they also assist other companies in bringing life-saving innovations to market, from clinical research to manufacturing, making them a key player in the development of game-changing cellular therapies.Generated from the website